Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Neoadjuvant Breast Cancer
NCT06176339Phase 2Active, not recruiting
- Sponsor
- Mansoura University
- Start
- Dec 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in breast cancer, sponsored by Mansoura University. Started Dec 2023; status: active, not recruiting.
02
Drugs
pentoxifylline
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06176339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06176339.